Motoharu Kawai

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

A serological analysis of viral and bacterial infections associated with neuromyelitis optica

Michiaki Koga, Toshiyuki Takahashi, Motoharu Kawai et al. · Journal of the Neurological Sciences · 2010 · 82 citations

Bacterial Infections, Ophthalmology, Neurovirology +12

Hydrocortisone Enhances the Function of the Blood-Nerve Barrier Through the Up-Regulation of Claudin-5

Yoko Kashiwamura, Yasuteru Sano, Masaaki Abe et al. · Neurochemical Research · 2011 · 54 citations

Blood-nerve Barrier, Neurophysiology, Medicine +9

Establishment and Characterization of Human Peripheral Nerve Microvascular Endothelial Cell Lines: A New <i>in vitro</i> Blood-Nerve Barrier (BNB) Model

Masaaki Abe, Yasuteru Sano, Toshihiko Maeda et al. · Cell Structure and Function · 2012 · 41 citations · Full text

Engineering, Blood-nerve Barrier, Immunology +22

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 37 citations · Full text